Home › Esophageal Cancer › New Jersey › Newark
Esophageal Cancer clinical trials in Newark, NJ
3 studies for Esophageal Cancer are looking for participants at sites in and around Newark (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Morristown Medical Center, Morristown · 17 mi away
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
RecruitingPhase 2
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
- Summit Medical Group (site 205), Florham Park · 12 mi away
- Atlantic Health System, Morristown Medical Center (site 124), Morristown · 17 mi away
About Esophageal Cancer
Early esophageal cancer does not have symptoms. Factors that increase risk include heavy drinking and smoking. Learn how you can reduce your risk.
More about Esophageal Cancer on MedlinePlus
Esophageal Cancer trials in other cities
- Houston, TX36 studies
- Boston, MA23 studies
- New York City, NY22 studies
- Nashville, TN19 studies
- St. Louis, MO17 studies
- Pittsburgh, PA15 studies
- Los Angeles, CA15 studies
- Grand Rapids, MI14 studies
- Baldwin Park, CA14 studies
- Philadelphia, PA13 studies
- San Antonio, TX12 studies
- Dallas, TX11 studies
Other studies in Newark
- Breast Cancer18 studies
- Spinal Cord Injuries13 studies
- Non-Small Cell Lung Cancer13 studies
- Acute Myeloid Leukemia12 studies
- Heart Failure10 studies
- Metastatic Cancer10 studies
- Cardiovascular Disease9 studies
- Pancreatic Cancer9 studies
- Melanoma8 studies
- Cancer (all types)7 studies
- Lung Cancer7 studies
- Crohn's Disease7 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.